BR112012000115B8 - composição compreendendo aminoácidos e/ou peptídeos bioativos e óleo marinho em uma emulsão óleo-em-água estável, processo para a produção e seus usos - Google Patents

composição compreendendo aminoácidos e/ou peptídeos bioativos e óleo marinho em uma emulsão óleo-em-água estável, processo para a produção e seus usos

Info

Publication number
BR112012000115B8
BR112012000115B8 BR112012000115A BR112012000115A BR112012000115B8 BR 112012000115 B8 BR112012000115 B8 BR 112012000115B8 BR 112012000115 A BR112012000115 A BR 112012000115A BR 112012000115 A BR112012000115 A BR 112012000115A BR 112012000115 B8 BR112012000115 B8 BR 112012000115B8
Authority
BR
Brazil
Prior art keywords
composition
oil
water emulsion
peptides
amino acids
Prior art date
Application number
BR112012000115A
Other languages
English (en)
Other versions
BR112012000115A2 (pt
BR112012000115B1 (pt
Inventor
Mathisen Henrik
Sande Mathisen Janne
Original Assignee
Smartfish As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smartfish As filed Critical Smartfish As
Publication of BR112012000115A2 publication Critical patent/BR112012000115A2/pt
Publication of BR112012000115B1 publication Critical patent/BR112012000115B1/pt
Publication of BR112012000115B8 publication Critical patent/BR112012000115B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A61K38/063—Glutathione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A23L2/66—Proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Edible Oils And Fats (AREA)

Abstract

composição compreendendo aminoácidos e/ou peptídeos bioativos e óleo marinho em uma emulsão óleo-em-água estável, e o uso da dita composição como uma composição funcional ou terapêutica. a presente invenção refere-se a suplementos alimentares. particularmente, a presente invenção refere-se a uma composição que compreende óleo marinho em uma emulsão óleo-em-água estável, compreen-dendo adicionalmente pelo menos um aminoácido ou peptídeo bioativo específico, ou derivados dos mesmos. além disso, a presente invenção refere-se a um processo para a produção da dita composição e o uso da dita composição como uma composição funcional ou terapêutica.
BR112012000115A 2009-07-06 2010-07-06 composição compreendendo aminoácidos e/ou peptídeos bioativos e óleo marinho em uma emulsão óleo-em-água estável, processo para a produção e seus usos BR112012000115B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NO20092564A NO333013B1 (no) 2009-07-06 2009-07-06 Sammensetning omfattende bioaktive aminosyrer eller derivater derav og marin olje i en stabil olje-i-vannemulsjon, og fremgangsmate for fremstilling av nevnte sammensetning.
NO20092564 2009-07-06
PCT/NO2010/000271 WO2011005113A1 (en) 2009-07-06 2010-07-06 Composition comprising bioactive amino acids and/or peptides and marine oil in a stable oil-in-water emulsion, and the use of said composition as a functional or therapeutic composition

Publications (3)

Publication Number Publication Date
BR112012000115A2 BR112012000115A2 (pt) 2016-03-15
BR112012000115B1 BR112012000115B1 (pt) 2020-10-27
BR112012000115B8 true BR112012000115B8 (pt) 2021-05-25

Family

ID=43429376

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012000115A BR112012000115B8 (pt) 2009-07-06 2010-07-06 composição compreendendo aminoácidos e/ou peptídeos bioativos e óleo marinho em uma emulsão óleo-em-água estável, processo para a produção e seus usos

Country Status (8)

Country Link
US (2) US20120148679A1 (pt)
EP (2) EP3375436A1 (pt)
CN (1) CN102711731B (pt)
AU (1) AU2010269242B2 (pt)
BR (1) BR112012000115B8 (pt)
CA (1) CA2764792C (pt)
NO (1) NO333013B1 (pt)
WO (1) WO2011005113A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10052352B2 (en) 2011-06-15 2018-08-21 Stable Solutions Llc Therapeutic application of parenteral krill oil
ES2643843T3 (es) * 2011-06-15 2017-11-24 Stable Solutions Llc Aplicación terapéutica de aceite de kril por vía parenteral
EP2882304A1 (en) * 2012-08-07 2015-06-17 Buck Institute For Research On Aging Multi-component formulation for improving neurological function
JP6120529B2 (ja) * 2012-11-12 2017-04-26 株式会社エムワイピー 鶏用飼料及び鶏の飼育方法
WO2014200356A1 (en) * 2013-06-13 2014-12-18 Smartfish As A marine oil formulation comprising reservatrol or derivatives thereof for use in treating, delaying and/or preventing alzheimer's desease
AU2014299410B2 (en) * 2013-06-27 2017-12-21 Smartfish As Use of a composition comprising fish oil and juice for the treatment of inflammation
MX2016007630A (es) * 2013-12-13 2016-09-09 Nestec Sa Uso de un suero de leche dulce modificado y una formula para bebes que contienen suero de leche dulce modificado para promover el desarrollo posnatal del sistema nervioso central infantil y las funciones cognitivas relacionadas.
NO20160913A1 (en) * 2016-05-27 2017-11-28 Smartfish As Use of a composition comprising marine oil and juice for improving muscle performance.
CN107494762A (zh) * 2017-08-24 2017-12-22 兰溪市捷喜食品加工技术有限公司 具有良好风味释放性的人造奶油及其制备方法
CN108208838A (zh) * 2018-03-09 2018-06-29 北京素维生物科技有限公司 一种掩味组合物及其用途
US11191289B2 (en) 2018-04-30 2021-12-07 Kraft Foods Group Brands Llc Spoonable smoothie and methods of production thereof
WO2021242044A1 (ko) * 2020-05-28 2021-12-02 포항공과대학교 산학협력단 히비스커스, 로즈마리, 및 포도씨 추출물을 유효성분으로 포함하는 퇴행성 뇌질환의 예방 또는 치료 조성물

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE55056T1 (de) * 1982-12-09 1990-08-15 Advanced Drug Tech Einfach absorbierbare fettsaeureemulsionen.
US6451341B1 (en) * 1990-02-05 2002-09-17 Thomas J. Slaga Time release formulation of vitamins, minerals and other beneficial supplements
SE9101642D0 (sv) * 1991-05-30 1991-05-30 Kabi Pharmacia Ab Phospholipids
US5514670A (en) 1993-08-13 1996-05-07 Pharmos Corporation Submicron emulsions for delivery of peptides
SE518823C2 (sv) 1994-07-12 2002-11-26 Karlshamns Lipidteknik Ab Olja-i-vatten-emulsioner
US6440464B1 (en) 1996-06-10 2002-08-27 Viva Life Science Nutritive composition for cardiovascular health containing fish oil, garlic, rutin, capsaicin, selenium, vitamins and juice concentrates
US7504376B2 (en) * 1996-08-12 2009-03-17 Natural Alternatives International Methods and compositions for increasing the anaerobic working capacity in tissues
AU5716300A (en) * 1999-06-25 2001-01-31 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Method for scavenging radicals with urocanic acid, derivatives and analogues
JP2001078702A (ja) * 1999-07-12 2001-03-27 Nippon Suisan Kaisha Ltd まろやかさ、後味、うま味が増強された調味料
JP3121331B1 (ja) 1999-09-13 2000-12-25 オーケー食品工業株式会社 惣菜の味付方法
GB9925709D0 (en) * 1999-10-30 1999-12-29 Smithkline Beecham Plc Composition
NO313076B1 (no) 1999-12-28 2002-08-12 Pronova Biocare As Flytende n¶rings- og/eller nytelsesmiddel og fremgangsmåte for fremstilling derav
NO312371B1 (no) * 2000-07-18 2002-04-29 Norsk Hydro As Fremgangsmåte ved stabilisering av umettede oljer
FR2820213B1 (fr) 2001-01-31 2004-10-22 Schlumberger Systems & Service Dispositif d'alimentation electrique pour une installation de tests de composants
US20050209183A1 (en) * 2002-07-25 2005-09-22 Phenion Gmbh & Co. Kg Cosmetic or pharmaceutical preparations comprising nucleic acids based on non-methylated CPG motifs
EP1585965A4 (en) * 2002-08-29 2009-05-13 Univ Massachusetts USE OF EMULSION RESTRICTING TECHNOLOGY FOR GENERATING OXIDATIVELY STABLE LIPID DELIVERY SYSTEMS
US20040087490A1 (en) * 2002-09-20 2004-05-06 Troup John P. Nutritional compositions
US20040219188A1 (en) * 2003-05-02 2004-11-04 Comer Gail M. Composition and methods for nutritional management of patients with hepatic disease
GB0314624D0 (en) * 2003-06-23 2003-07-30 Advanced Bionutrition Europ Lt Inflammatory disease treatment
US8628690B2 (en) * 2004-02-23 2014-01-14 The Texas A&M University System Nanoemulsion compositions and methods of use thereof
US20080020102A1 (en) * 2004-07-13 2008-01-24 Rutgers, The State University Of New Jersey Omega Fatty Acid Fortified Food Products And Methods For Preparing Same
NO322041B1 (no) * 2004-10-22 2006-08-07 Pharmalogica As Naeringsmiddelsupplement inneholdende fiskeolje og melkefaststoff som emulgator og fremgangsmate for fremstilling.
NO323665B1 (no) * 2005-06-27 2007-06-18 Pharmalogica As Drikk omfattende fiskeolje og probiotiske bakterier og fremgangsmate for fremstilling.
US20090202679A1 (en) * 2005-11-29 2009-08-13 Pharmalogica As Composition comprising fish oil and juices
NO327925B1 (no) * 2007-06-25 2009-10-19 Pharmalogica As Anvendelse av kullsyre i drikker omfattende polyumettede fettsyrer (PUFA) for a hindre oksidasjon av fettsyrene.
HUP0700552A2 (en) 2007-08-27 2009-03-30 Janos Dr Feher Method and composition inhibiting inflammation

Also Published As

Publication number Publication date
BR112012000115A2 (pt) 2016-03-15
CN102711731B (zh) 2015-02-18
EP2451439A4 (en) 2013-09-11
BR112012000115B1 (pt) 2020-10-27
AU2010269242B2 (en) 2014-05-22
CA2764792A1 (en) 2011-01-13
EP3375436A1 (en) 2018-09-19
WO2011005113A1 (en) 2011-01-13
NO20092564A1 (no) 2011-01-07
US20120148679A1 (en) 2012-06-14
US20140287054A1 (en) 2014-09-25
NO333013B1 (no) 2013-02-18
CN102711731A (zh) 2012-10-03
CA2764792C (en) 2019-01-15
AU2010269242A1 (en) 2012-01-19
US10105401B2 (en) 2018-10-23
EP2451439A1 (en) 2012-05-16

Similar Documents

Publication Publication Date Title
BR112012000115B8 (pt) composição compreendendo aminoácidos e/ou peptídeos bioativos e óleo marinho em uma emulsão óleo-em-água estável, processo para a produção e seus usos
ECSP099332A (es) Moléculas de enlace de lingo y uso farmacéutico de las mismas
BR112012022223A8 (pt) Formulação de proteína concentrada, uso e método de preparação da mesma
BR112018013032A2 (pt) preparação enzimática líquida e método para o preparo da mesma
BR112013028407A2 (pt) "sequências de aminoácido direcionadas em relação aos polipeptídeos de il-17a, il-17f e/ou il17-a/f compreendendo as mesmas, seus usos, polipeptídeos, e composição farmacêutica".
BRPI0717183B8 (pt) exendina ou análogo de exendina modificada por peg, composição e seu uso
BR112015021033A8 (pt) composição cosmética, métodos para regular ou prevenir uma condição de pele, para reduzir ou tratar sinais de envelhecimento de pele e para prevenir, clarear ou reduzir o aparecimento de descontinuidades visíveis da pele e usos de uma composição
BR112015008552A2 (pt) material cristalino, composição farmacêutica, e, processo para a preparação de um material cristalino
BR112013026883A2 (pt) Composição farmacêutica, kit compreendendo uma composição e método de produção de uma composição farmacêutica
ECSP19025350A (es) Anticuerpos monoclonales optimizados contra el inhibidor de la vía del factor tisular (tfpi)
ECSP13012668A (es) Ácidos 1-bencilcicloalquilcarboxílicos sustituidos y su uso
ECSP17043318A (es) Composición que contiene quitina y proteínas digeribles
ECSP11011278A (es) Composición farmacéutica que comprende derivados de glucopiranosil difenilmetano, forma farmacéutica de la misma, procedimiento para su preparación y usos de la misma para el control glucémico mejorado en un paciente.
BRPI0905733B8 (pt) composição, formulação farmacêutica, método para a produção de uma composição farmacêutica e uso de uma formulação farmacêutica
BR112012024379A2 (pt) "peptídeos glucagon, seu uso, bem como composição farmacêutica"
CO2017009433A2 (es) Proteínas específicas para pioverdina y pioquelina
BR112014017913A8 (pt) Cosmético na forma de uma emulsão, kit e processo para melhora da aparência da pele
BR112017015773A2 (pt) muteína de lipocalina, muteína de hngal, molécula de ácido nucleico, célula hospedeira, método para produzir a muteína de hngal, composição farmacêutica, kit, uso da muteína de hngal, uso da muteína de hngal, método para ligar ang-2 em um indivíduo, método para inibir angiogênese em um indivíduo, método para tratar, prevenir ou melhorar uma doença e método para inibir ou reduzir angiogênese em um indivíduo
BR112015002372A2 (pt) composições e métodos para a redução do teor de álcool no sangue
BR112013002865A2 (pt) produto de confeitaria congelado com um estabilizador natural
CO6470849A2 (es) Proceso para la obtención de un concentrado de ésteres de ácidos eicosapentaenoico y docosahexaenoico
CL2009001484A1 (es) Sal glicinato de metformina; composición farmacéutica que comprende la sal; y su uso para tratar la hiperglicemia.
EA201070419A1 (ru) Состав для регулирования метаболизма липидов
BR112016002103A8 (pt) método para a produção de material queratinoso hidrolisado altamente digerível, material queratinoso hidrolisado altamente digerível, e, uso de um material queratinoso hidrolisado altamente digerível
BR112014033102A2 (pt) produto para uso no tratamento profilático ou terapêutico de uma emoção negativa ou comportamento introvertido

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 35/60 (2006.01), A23L 2/52 (2006.01), A23L 2/

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 27/10/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 06/07/2010 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF